Abstract：Objective: To explore the diagnostic value of placental growth factor (PLGF),high mobility group protein B1 (HMGB1) and myeloperoxidase (MPO) levels in hypertensive disorder complicating pregnancy. Methods: A total of 112 patients with hypertensive disorder in pregnancy who were treated in our hospital were selected as the observation group,112 healthy pregnant women were selected as the control group,and the differences of serum PLGF,HMGB1,and MPO levels were compared,and the differences of serum PLGF,HMGB1,and MPO levels in patients with different severity and pregnancy outcome in the observation group were analyzed,and the value of PLGF,HMGB1,and MPO in diagnosing severe preeclampsia and adverse pregnancy outcomes were analyzed. Results: Compared with the control group,the serum PLGF of the observation group was (46.63 ± 9.97) pg/mL,which was lower (P<0.05),while HMGB1 and MPO were (60.43±11.41) mmol/L and (14.46±1.38) ng/L,respectively,which was higher (P<0.05).The serum PLGF of patients with severe preeclampsia was (37.12±8.85) pg/mL,which was lower than that of patients with hypertensive disorder in pregnancy and mild preeclampsia (P<0.05),while HMGB1 and MPO were (72.78±9.83) mmoL/L and (16.09±1.40) ng/L,respectively,which were higher than those of patients with hypertensive disorder in pregnancy and mild preeclampsia (P<0.05).The serum PLGF of patients with adverse pregnancy outcome in the observation group was (40.41±8.21) pg/mL,which was lower than those without adverse pregnancy outcome (P<0.05),while HMGB1 and MPO were (69.56±8.97) mmoL/L and (16.12±1.97) ng/L,respectively,which were higher than those without adverse pregnancy outcome (P<0.05).The area under the ROC curve of serum PLGF,HMGB1,MPO diagnosis of severe preeclampsia were 0.723,0.805,0.869,respectively,P<0.05.The area under the ROC curve of serum PLGF,HMGB1,MPO prediction of adverse pregnancy outcomes were 0.797,0.829,0.751,respectively,P<0.05. Conclusion: The decrease of serum PLGF level and the increase of HMGB1 and MPO level in patients with hypertensive disorder in pregnancy have a certain relationship with the severity of the disease and adverse pregnancy outcomes,and have a certain value in predicting severe pre-eclampsia and adverse pregnancy outcomes.
李晖, 梅小琴, 焦顺, 潘琴, 刘荣. PLGF HMGB1及MPO水平对妊娠期高血压疾病的诊断价值研究[J]. 河北医学, 2023, 29(7): 1094-1098.
LI Hui, MEI Xiaoqin, JIAO Shun, et al. Study on the Diagnostic Value of PLGF HMGB1 and MPO Levels in Hypertensive Disorder in pregnancy. HeBei Med, 2023, 29(7): 1094-1098.
2023, Vol. 29 
冀公网安备13080202000677号